Meriofert Kit (Follicle-Stimulating Hormone, Luteinising Hormone)

The two hormones bind to specific FSH and LH receptors on ovarian cells. Activation of these receptors promotes follicle growth, estrogen production, and the LH surge that triggers ovulation, thereby facilitating the development of a mature oocyte for fertilisation.

The dose of Meriofert Kit is individualised by the prescribing clinician based on the patient’s ovarian response, treatment protocol and underlying condition. Dosage regimens are not standardised and should follow the prescriber’s instructions.

Meriofert Kit is intended for use before conception to induce ovulation. Its safety in established pregnancy or while breastfeeding has not been established, and it should not be used during those periods unless specifically advised by a qualified healthcare professional.

To order, submit an enquiry on the Meriofert Kit product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Meriofert Kit combines both FSH and LH activities in a single injectable formulation, which can simplify dosing compared with separate FSH‑only preparations. Clinical efficacy is comparable to other recombinant gonadotropins, while the safety profile reflects the class‑wide risks of ovarian stimulation.

Store Meriofert Kit at 2‑8 °C in a refrigerator. Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the vial. Do not use if the solution appears discoloured or contains particles.

Meriofert Kit is administered by a healthcare professional via intramuscular or subcutaneous injection, typically into the thigh or abdomen. The exact injection technique and site should follow the prescriber’s guidance and standard aseptic procedures.

Serious risks include ovarian hyperstimulation syndrome, which can cause abdominal pain, rapid weight gain and, in severe cases, fluid accumulation; multiple pregnancy; severe allergic reactions; and rare thromboembolic events. Patients should be monitored closely for these complications.

Meriofert Kit should be avoided in individuals with known hypersensitivity to any component of the product, active ovarian cysts, uncontrolled thyroid disease, or those who are currently pregnant or breastfeeding unless directed by a specialist.